|
Total bilirubin (μmol/L)
|
113
|
1.13 (0.14)
|
1.09 (0.15)
|
0.23-1.35
|
0.002
|
In normal range but significantly decreased after treatment
|
|
Total protein (g/L)
|
114
|
65.03 (5.27)
|
63.20 (6.27)
|
60.0-85.0
|
0.002
|
In normal range but significantly decreased after treatment
|
|
Glutamic-pyruvic transaminase, (GPT) (U/L)
|
114
|
1.37 (0.22)
|
1.33 (0.20)
|
0.7-1.65
|
0.037
|
In normal range but significantly decreased after treatment
|
|
Glutamic-oxaloacetic transaminase (GOT) (U/L)
|
114
|
23.60 (12.45)
|
21.01 (8.56)
|
5.0-45.0
|
0.005
|
In normal range but significantly decreased after treatment
|
|
Serum urea nitrogen (BUN) (μmol/L)
|
114
|
4.63 (1.58)
|
4.58 (1.88)
|
2.0-7.1
|
0.750
|
In normal range, no significant difference
|
|
Serum creatinine (SCR) (μmol/L)
|
114
|
1.81 (0.16)
|
1.81 (0.16)
|
1.64-2.12
|
0.898
|
In normal range, no significant difference
|
|
Uric acid (UA) (μmol/L)
|
114
|
308.27 (80.88)
|
309.28 (89.64)
|
90.0-440.0
|
0.871
|
In normal range, no significant difference
|
